News

In this blog to support Rare Disease Day Pharmora Chief Medical Officer, Dr Stephanie Jones, has provided tips for Innovators developing new products to diagnose or treat rare diseases, and a checklist to help people affected by these conditions who are looking for these innovations.

This is the final instalment of our series of blogs which detail just a few women and girls’ experiences of being a woman in a scientific field. In this final blog, we hear from one of our staff about her journey from a scientifically-inclined child, to the scientist she is today.

Today we are celebrating International Epilepsy Day! By understanding the condition, we can support ongoing research and raise awareness for the 50 million people living with epilepsy globally.

This is the second of our series of blogs which detail just a few women and girls’ experiences of being a woman in a scientific field. In this second instalment, we hear from one of our work experience students who’s studying A-Level Biology and is fighting for more recognition of women and girls in the sciences.

This is the first of our series of blogs detailing just a few women and girls’ experiences of being a woman in a scientific field. In this first post, we hear from an inspired GCSE student who will be studying 2 sciences at A-Level with a brief foreword from our CMO, Dr Stephanie Jones.

Dr Jones was delighted to meet with Dr Sheuli Porkess, Director of Actaros Consultancy and President of the Faculty of Pharmaceutical Medicine to talk about some hot topics in our industry! Read on to hear their insights on AI and the challenges of encouraging diversity in our industry…

Hereditary Cancer Awareness Week raises awareness of inherited cancer risks such as BRCA and Lynch syndrome. Learn how family history, genetic testing, and new research in population screening and polygenic risk scores are shaping the future of cancer prevention.

This year’s World Patient Safety Day highlights “Patient safety from the start: safe care for every newborn and child”. We support safer outcomes for children and vulnerable patients through rigorous data review, pregnancy precautions, and paediatric safety expertise. Read more.

Mitochondria are often called the “powerhouses” of our cells, but when their DNA carries variants, families can face difficult and lifelong health challenges. We are marking World Mitochondrial Disease Week with this educational blog – read on to learn more.

AI in biosciences has been a developing topic for discussion at many recent conferences, so it was time it got its own! Read on to learn more about the BioAI conference…

Schizophrenia is a commonly misunderstood mental health condition which 1 in 300 people have worldwide. It is important to spread awareness this National Schizophrenia Awareness Day so those who need support can access it. Read on to find out more.

Gaucher disease is a rare genetic disorder caused by a deficiency in the enzyme glucocerebrosidase, leading to a harmful buildup of fat in cells. This causes symptoms like enlarged organs, bone pain, and, in some cases, neurological impairment. Current treatments offer relief but come with limitations such as inconvenient infusions, side effects, and the inability to address neurological symptoms. Read on to discover the promising new developments bringing hope for this rare disease…

The MHRA launched the Patient Involvement Strategy 2021-2025. Now, in the final year of the strategy, what has been done for Patient Involvement, and what do the MHRA plan to do next? Read on to learn…

The EMA is transitioning all of the communications during the Marketing Authorisation process to its IRIS platform, read on to learn more about what this might mean for you.

In recent years, patient-centricity and patient-focus have been mentioned frequently in discussions about the future of the pharmaceutical industry. Pharmora have written a series of blogs to dissect and discuss this trend, read on to learn more…

Reflecting on the current landscape of oncological drug development, Pharmora would like to take this opportunity to raise awarenesses of rare cancers that need more attention. In this blog, we put a spotlight on Sarcoma, where we summarise what sarcoma cancer is, what is in development in the changing treatment landscape, and what could be done in the future.

Gastric (stomach) and Oesophageal cancer are among the least survivable cancers. Read on to learn about the differences in symptoms and in causes for these two cancers, and find out more about ongoing studies in this area…

Celebrating the awareness week for Less Survivable Cancers, Pharmora is contributing to this campaign through a series of blogs. Liver cancer is classed as a ‘less survivable cancer’, but what is the past and the current landscape of treatment for this disease? Read on to find out…

Urgent reminder of the Windsor Framework: the deadline is approaching! This is especially important for all medicines manufacturers with a current PLNI and PLGB licence. They need to urgently to cancel their PLNI to be automatically converted to a UK licence. Read on to find out more…

Pharmora can help bring more medicines to the patients who benefit from them, helping the patient and the manufacturer. Read more to find out how!
In this first blog of two the CMO describes the context of our work

Have you ever experienced an adverse event after taking a medication? Did you tell a healthcare professional about it? Would you know how to report it? Read on to find out why it is important to report!

The theme for #medsafetyweek2024 is “The importance of using medicines correctly to prevent side effects”. In order to do this we need some information on correct use. Where do we find this? Read on to find out!